Evaluating current implantable cardioverter defibrillator implantation procedures: can common complications be minimised?

References

• Mirowski M, Reid PR, Mower MM, et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med. 1980;303:322–324.
   PubMed Web of Science ®Google Scholar
• Jordaens L, Waleffe A, Derom F, et al. Experience with the automatic implantable defibrillator. Acta Clin Belg. 1988;43:209–218.
   PubMed Web of Science ®Google Scholar
• Jordaens L, Vertongen P, Provenier F, et al. A new transvenous internal cardioverter-defibrillator: implantation technique, complications and short term follow-up. Am Heart J. 1995;129:251–258.
   PubMed Web of Science ®Google Scholar
• Pacifico A, Wheelan KR, Nasir N Jr, et al. Long-term follow-up of cardioverter-defibrillator implanted under conscious sedation in prepectoral subfascial position. Circulation. 1997;95:946–950.
   PubMed Web of Science ®Google Scholar
• van Rees JB, de Bie MK, Thijssen J, et al. Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trials. J Am Coll Cardiol. 2011;58:995–1000.
   PubMed Web of Science ®Google Scholar
• Ong JJC, Hsu PC, Lin L, et al. Arrhythmias after cardioverter defibrillator implantation. Comparison of epicardial and transvenous systems. Am J Cardiol. 1995;75:137–140.
   PubMed Web of Science ®Google Scholar
• Gradaus R, Block M, Brachmann J, et al. Mortality, morbidity, and complications in 3344 patients with implantable cardioverter defibrillators: results from the German ICD Registry EURID. Pacing Clin Electrophysiol. 2003;26:1511–1518.
   PubMed Web of Science ®Google Scholar
• Dodson JA, Lampert R, Wang Y, et al. Temporal trends in quality of care among recipients of implantable cardioverter-defibrillators: insights from the National Cardiovascular Data Registry. Circulation. 2014;129:580–586.
   PubMed Web of Science ®Google Scholar
• Padfield GJ, Steinberg C, Bennett MT, et al. Preventing cardiac implantable electronic device infections. Heart Rhythm. 2015;12:2344–2356.
   PubMed Web of Science ®Google Scholar
• Ezzat VA, Lee V, Ahsan S, et al. A systematic review of ICD complications in randomised controlled trials versus registries: is our ‘real-world’ data an underestimation? Open Heart. 2015;2(1):e000198.
   PubMedGoogle Scholar
• Hauser RG. The growing mismatch between patient longevity and the service life of implantable cardioverter-defibrillators. J Am Coll Cardiol. 2005;45:2022–2025.
   PubMed Web of Science ®Google Scholar
• Kleemann T, Becker T, Doenges K, et al. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation. 2007;115:2474–2480.
   PubMed Web of Science ®Google Scholar
• Valk SD, Theuns DA, Jordaens L. Long-term performance of the St Jude Riata 1580–1582 ICD lead family. Neth Heart J. 2013;21:127–134.
   PubMed Web of Science ®Google Scholar
• Smith T, Van Dessel PF, Theuns DAMJ, et al. Health care utilisation after defibrillator implantation for primary prevention according to the guidelines in 2 Dutch academic medical centres. Neth Heart J. 2011;19:405–411.
   PubMed Web of Science ®Google Scholar
• Prutkin JM, Reynolds MR, Bao H, et al. Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry. Circulation. 2014;130:1037–1043.
   PubMed Web of Science ®Google Scholar
• Pedersen SS, Hoogwegt MT, Jordaens L, et al. Procedure- and device-related complications and psychological morbidity in implantable cardioverter defibrillator patients. Int J Cardiol. 2013;168:606–607.
   PubMed Web of Science ®Google Scholar
• Klug D, Balde M, Pavin D, et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation. 2007;116:1349–1355.
   PubMed Web of Science ®Google Scholar
• Poole JE, Gleva MJ, Mela T, et al. REPLACE Registry Investigators. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation. 2010;122:1553–1561.
   PubMed Web of Science ®Google Scholar
• Greenspon AJ, Patel JD, Lau E, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol. 2011;58:1001–1006.
   PubMed Web of Science ®Google Scholar
• Nielsen JC, Gerdes JC, Varma N. Infected cardiac-implantable electronic devices: prevention, diagnosis, and treatment. Eur Heart J. 2015;36:2484–2490.
   PubMed Web of Science ®Google Scholar
• Remmelts HH, Meine M, Loh P, et al. Infection after ICD implantation: operating room versus cardiac catheterisation laboratory. Neth Heart J. 2009;17:95–100.
   PubMed Web of Science ®Google Scholar
• Fox DJ, Davidson NC, Bennet DH, et al. Safety and acceptability of implantation of internal cardioverter-defibrillators under local anesthetic and conscious sedation. Pacing Clin Electrophysiol. 2007;30:992–997.
   PubMed Web of Science ®Google Scholar
• Trouvé-Buisson T, Arvieux L, Bedague D, et al. Anaesthesiological support in a cardiac electrophysiology laboratory: a single-centre prospective observational study. Eur J Anaesthesiol. 2013;30:658–663.
   PubMed Web of Science ®Google Scholar
• Haydin S, Saygi M, Ergul Y, et al. Subxiphoid approach to epicardial implantation of implantable cardioverter defibrillators in children. Pacing Clin Electrophysiol. 2013;36:926–930.
   PubMed Web of Science ®Google Scholar
• Jordaens L, Vertongen P, van Belleghem Y. A subcutaneous lead array for implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 1993;16:1429–1433.
   PubMed Web of Science ®Google Scholar
• Kriebel T, Ruschewski W, Gonzalez y Gonzalez M, et al. ICD implantation in infants and small children: the extracardiac technique. Pacing Clin Electrophysiol. 2006;29:1319–1325.
   PubMed Web of Science ®Google Scholar
• Parsonnet V, Roelke M. The cephalic vein cutdown versus subclavian puncture for pacemaker/ICD lead implantation. Pacing Clin Electrophysiol. 1999;22:695–697.
   PubMed Web of Science ®Google Scholar
• Gallik DM, Ben-Zur UM, Gross JN, et al. Lead fracture in cephalic versus subclavian approach with transvenous implantable cardioverter defibrillator systems. Pacing Clin Electrophysiol. 1996;19:1089–1094.
   PubMed Web of Science ®Google Scholar
• Roelke M, O’Nunain SS, Osswald S, et al. Subclavian crush syndrome complicating transvenous cardioverter defibrillator systems. Pacing Clin Electrophysiol. 1995;18:973–979.
   PubMed Web of Science ®Google Scholar
• Lau EW. Axillary/subclavian vein puncture using navigation by parallax with an imaginary target. Pacing Clin Electrophysiol. 2007;30:1531–1541.
   PubMed Web of Science ®Google Scholar
• Bardy GH, Smith WM, Hood MA, et al. An entirely subcutaneous implantable cardioverter-defibrillator. New Engl J Med. 2010;363:36–44.
   PubMed Web of Science ®Google Scholar
• Shefer A, Lewis BS, Gang ES. The retropectoral transaxillary permanent pacemaker: description of a technique for percutaneous implantation of an “invisible” device. Pacing Clin Electrophysiol. 1996;19:1646–1651.
   PubMed Web of Science ®Google Scholar
• Babuty D, Mirza A, Clementy N, et al. Left retropectoral axillary implantation of defibrillators in young women. Ann Thorac Surg. 2012;93:331–333.
   PubMed Web of Science ®Google Scholar
• McHugh SM, Hill AD, Humphreys H. Intraoperative technique as a factor in the prevention of surgical site infection. J Hosp Infect. 2011;78:1–4.
   PubMed Web of Science ®Google Scholar
• Baddour LM, Epstein AE, Erickson CC, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010;121:458–477.
   PubMed Web of Science ®Google Scholar
• Mera F, DeLurgio DB, Langberg JJ, et al. Transvenous cardioverter defibrillator lead malfunction due to terminal connector damage in pectoral implants. Pacing Clin Electrophysiol. 1999;22:1797–1801.
   PubMed Web of Science ®Google Scholar
• Cantillon DJ, Ha K, Styperek R, et al. Clinical experience and procedural outcomes associated with the DF4 implantable cardioverter defibrillator system: the SJ4 postapproval study. Pacing Clin Electrophysiol. 2013;36:855–862.
   PubMed Web of Science ®Google Scholar
• Antonelli D, Rosenfeld T, Freedberg NA, et al. Insulation lead failure: is it a matter of insulation coating, venous approach, or both? Pacing Clin Electrophysiol. 1998;21:418–421.
   PubMed Web of Science ®Google Scholar
• Al-Khatib SM, Lucas FL, Jollis JG, et al. The relation between patients’ outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating Medicare Beneficiaries. J Am Coll Cardiol. 2005;46:1536–4.
   PubMed Web of Science ®Google Scholar
• Freeman JV, Wang Y, Curtis JP, et al. Physician procedure volume and complications of cardioverter-defibrillator implantation. Circulation. 2012;125:57–64.
   PubMed Web of Science ®Google Scholar
• Krahn AD, Lee DS, Birnie D, et al. Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD Database. Circ Arrhythm Electrophysiol. 2011;4:136–142.
   PubMed Web of Science ®Google Scholar
• Curtis JP, Luebbert JJ, Wang Y, et al. Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator. J Am Med Assoc. 2009;301:1661–1670.
   Web of Science ®Google Scholar
• Aktas MK, Huang DT, Daubert JP, et al. Effect of defibrillation threshold testing on heart failure hospitalization or death in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Heart Rhythm. 2013;10:193–199.
   PubMed Web of Science ®Google Scholar
• Francis CK, Kuo YH, Azzam I, et al. Brain natriuretic peptide and biomarkers of myocardial ischemia increase after defibrillation threshold testing. Pacing Clin Electrophysiol. 2012;35:314–319.
   PubMed Web of Science ®Google Scholar
• Killingsworth CR, Melnick SB, Litovsky SH, et al. Evaluation of acute cardiac and chest wall damage after shocks with a subcutaneous implantable cardioverter-defibrillator in swine. Pacing Clin Electrophysiol. 2013;36:1265–1272.
   PubMed Web of Science ®Google Scholar
• Healey JS, Hohnloser SH, Glikson M, et al. Shockless IMPLant Evaluation [SIMPLE] investigators. Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE). Lancet. 2015;385(9970):785–791.
   PubMed Web of Science ®Google Scholar
• Bänsch D, Bonnemeier H, Brandt J, et al. NORDIC ICD Trial Investigators. Intra-operative defibrillation testing and clinical shock efficacy in patients with implantable cardioverter-defibrillators: the NORDIC ICD randomized clinical trial. Eur Heart J. 2015;36:2500–2507.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Juanatey C, Testa A, Vidan J, et al. Persistent left superior vena cava draining into the coronary sinus: report of 10 cases and literature review. Clin Cardiol. 2004;27:515–518.
   PubMed Web of Science ®Google Scholar
• Abu-El-Haija B, Bhave PD, Campbell DN, et al. Venous stenosis after transvenous lead placement: a study of outcomes and risk factors in 212 consecutive patients. J Am Heart Assoc. 2015;4:e001878.
   Web of Science ®Google Scholar
• Van Durme JP, Heyndrickx G, Snoeck J, et al. Diagnosis of myocardial perforation by intracardiac electrograms recorded from the indwelling catheter. J Electrocardiol. 1973;6:97–102.
   PubMed Web of Science ®Google Scholar
• Cano O, Andrés A, Alonso P, et al. Incidence and predictors of clinically relevant cardiac perforation associated with systematic implantation of active-fixation pacing and defibrillator leads: a single-center experience with over 3800 implanted leads. Europace. Forthcoming 2016;18.
   Google Scholar
• Burke MC, Gold MR, Knight BP, et al. Safety and efficacy of the totally subcutaneous implantable defibrillator. 2-year results from a pooled analysis of the IDE study and EFFORTLESS registry. J Am Coll Cardiol. 2015;65:1605–1615.
   PubMed Web of Science ®Google Scholar
• Knops R, Olde Nordkamp L, de Groot J, et al. Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator. Heart Rhythm. 2013;10:1240–1243.
   PubMed Web of Science ®Google Scholar
• Olde Nordkamp LRA, Dabiri Abkenari L, Boersma LV, et al. The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort. J Am Coll Cardiol. 2012;60:1933–1939.
   PubMed Web of Science ®Google Scholar
• Lekkerkerker JC, van Nieuwkoop C, Trines SA, et al. Risk factors and time delay associated with cardiac device infections: Leiden Device Registry. Heart. 2009;95:715–720.
   PubMed Web of Science ®Google Scholar
• Bernard ML, Shotwell M, Nietert PJ, et al. Meta-analysis of bleeding complications associated with cardiac rhythm device implantation. Circ Arrhythm Electrophysiol. 2012;5:468–474.
   PubMed Web of Science ®Google Scholar
• Birnie DH, Healey JS, Wells GA, et al. BRUISE CONTROL Investigators. Pacemaker or defibrillator surgery without interruption of anticoagulation. N Engl J Med. 2013;368:2084–2093.
   PubMed Web of Science ®Google Scholar
• Robinson M, Healey JS, Eikelboom J, et al. Post-operative low-molecular-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators. Pacing Clin Electrophysiol. 2009;32:378–382.
   PubMed Web of Science ®Google Scholar
• Da Costa A, Kirkorian G, Cucherat M, et al. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation. 1998;97:1796–1801.
   PubMed Web of Science ®Google Scholar
• de Oliveira JC, Martinelli M, D’Orio Nishioka SA, et al. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial. Circ Arrhythm Electrophysiol. 2009;2:29–34.
   PubMed Web of Science ®Google Scholar
• Ahsan SY, Saberwal B, Lambiase PD, et al. A simple infection-control protocol to reduce serious cardiac device infections. Europace. 2014;16:1482–1489.
   PubMed Web of Science ®Google Scholar
• Jordan JR, Bloom HL. Prevention of bacteral infections in patients with cardiac implantable devices: old traditions meet new technology. J Innov Card Rhythm Manage. 2010;1:63–71.
   Google Scholar
• Darouiche RO, Wall MJJ, Itani KMF, et al. Chlorhexidine- alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med. 2010;362:18–26.
   PubMed Web of Science ®Google Scholar
• Graux P, Lequeuche B, Guyomar Y, et al. Prévention polyfactorielle des endocardites et stimulateurs cardiaques: Une étude prospective à propos de 207 patients [Multifactorial prevention of endocarditis and cardiac pacemaker. A prospective study of 207 patients]. Ann Cardiol Angeiol. 1996;45:113–118.
   PubMedGoogle Scholar
• Hirsh DS, Bloom HL. Clinical use of antibacterial mesh envelopes in cardiovascular electronic device implantations. Med Devices. 2015;8:71–78.
   Google Scholar
• Bloom HL, Constantin L, Dan D, et al. Cooperative Multicenterstudy Monitoring a CIED ANtimicrobial Device Investigators. Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelope. Pacing Clin Electrophysiol. 2011;34:133–142.
   PubMed Web of Science ®Google Scholar
• Kolek MJ, Dresen WF, Wells QS, et al. Use of an antibacterial envelope is associated with reduced cardiac implantable electronic device infections in high-risk patients. Pacing Clin Electrophysiol. 2013;36:354–361.
   PubMed Web of Science ®Google Scholar
• Goldenberg I, Vyas AK, Hall WJ, et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol. 2008;51:288–296.
   PubMed Web of Science ®Google Scholar
• Goldenberg I, Moss AJ, McNitt S, et al. Multicenter Automatic Defibrillator Implantation Trial-II Investigators. Relations among renal function,risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction. Am J Cardiol. 2006;98:485–490.
   PubMed Web of Science ®Google Scholar
• Smith T, Levy WC, Schaer BA, et al. Performance of the Seattle Heart Failure model in implantable defibrillator patients treated with cardiac resynchronization therapy. Am J Cardiol. 2012;110:398–402.
   PubMed Web of Science ®Google Scholar
• Bloom H, Heeke B, Leon A, et al. Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing Clin Electrophysiol. 2006;29:142–145.
   PubMed Web of Science ®Google Scholar
• Herce B, Nazeyrollas P, Lesaffre F, et al. Risk factors for infection of implantable cardiac devices: data from a registry of 2496 patients. Europace. 2013;15:66–70.
   PubMed Web of Science ®Google Scholar
• Silvetti MS, Placidi S, Palmieri R, et al. Percutaneous axillary vein approach in pediatric pacing: comparison with subclavian vein approach. Pacing Clin Electrophysiol. 2013;36:1550–1557.
   PubMed Web of Science ®Google Scholar
• Pettit SJ, McLean A, Colquhoun I, et al. Clinical experience of subcutaneous and transvenous implantable cardioverter defibrillators in children and teenagers. Pacing Clin Electrophysiol. 2013;36:1532–1538.
   PubMed Web of Science ®Google Scholar
• Stephenson EA, Batra AS, Knilans TK, et al. A multicenter experience with novel implantable cardioverter defibrillator configurations in the pediatric and congenital heart disease population. J Cardiovasc Electrophysiol. 2006;17:41–46.
   PubMed Web of Science ®Google Scholar
• Silka MJ, Bar-Cohen Y. A contemporary assessment of the risk for sudden cardiac death in patients with congenital heart disease. Pediatr Cardiol. 2012;33:452–460.
   PubMed Web of Science ®Google Scholar
• Zeb M, Curzen N, Veldtman G, et al. Potential eligibility of congenital heart disease patients for subcutaneous implantable cardioverter-defibrillator based on surface electrocardiogram mapping. Europace. 2015;17:1059–1067.
   PubMed Web of Science ®Google Scholar
• Heersche JHM, Blom NA, van de Heuvel F, et al. Implantable cardioverter defibrillator therapy for prevention of sudden cardiac death in children in the Netherlands. Pacing Clin Electrophysiol. 2010;33:179–185.
   PubMed Web of Science ®Google Scholar
• McLeod KA, McLean A. Implantation of a fully subcutaneous ICD in children. Pacing Clin Electrophysiol. 2012;35:20–23.
   Web of Science ®Google Scholar
• Bordachar P, Christelle Marquié C, Pospiech T, et al. Subcutaneous implantable cardioverter defibrillators in children, young adults and patients with congenital heart disease. Int J Cardiol. 2016;203:251–258.
   PubMed Web of Science ®Google Scholar
• Olde Nordkamp LR, Postema PG, Knops RE, et al. Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: a systematic review and meta-analysis of inappropriate shocks and complications. Heart Rhythm. 2015;pii:S1547–5271.
   Google Scholar
• Schinkel AFL, Vriesendorp PA, Sijbrands EJG, et al. Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis. Circ Heart Fail. 2012;5:552–559.
   PubMed Web of Science ®Google Scholar
• Jarman JWE, Lascelles K, Wong T, et al. Clinical experience of entirely subcutaneous implantable cardioverter-defibrillators in children and adults: cause for caution. Eur Heart J. 2012;33:1351–1359.
   PubMed Web of Science ®Google Scholar
• Schinkel AFL. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications. Circ Arrhythm Electrophysiol. 2013;6:562–568.
   PubMed Web of Science ®Google Scholar
• Schwartz PJ, Spazzolini C, Priori SG, et al. Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them? Data from the European Long-QT syndrome implantable cardioverter-defibrillator (LQTS ICD) registry. Circulation. 2010;122:1272–1282.
   PubMed Web of Science ®Google Scholar
• Heidbuchel H, Carré F. Exercise and competitive sports in patients with an implantable cardioverter-defibrillator. Eur Heart J. 2014;35:3097–3102.
   PubMed Web of Science ®Google Scholar
• Kleemann T, Becker T, Strauss M, et al. Prevalence of bacterial colonization of generator pockets in implantable cardioverter defibrillator patients without signs of infection undergoing generator replacement or lead revision. Europace. 2010;12:58–63.
   PubMed Web of Science ®Google Scholar
• Rivero-Ayerza M, Thornton A, Theuns DAMJ, et al. Left ventricular lead placement within a coronary sinus side branch using remote magnetic navigation of a guidewire: a feasibility study. J Cardiovasc Electrophysiol. 2006;17:128–133.
   PubMed Web of Science ®Google Scholar